In addition to its well known stimulation of cAMP production, the human melanocortin type 4 (hMC4) receptor recently has been shown to mediate p44/42 NIAPK activation. This finding opens new questions about the structural and signaling mechanisms that connect the receptor to this alternate cell signaling pathway. Point mutants in the hMC4 receptor that have been associated with obesity were constructed and transfected into HEK 293 cells. Functional analyses then were done to determine if these mutations would similarly impact cAMP formation and p44/42 MAPK signaling. Whereas a D90N mutation in the second transmembrane domain and a D298A mutation in the seventh transmembrane domain impaired both cAMP formation and p44/42 MAPK activation, a more conservative D298N mutation retained cAMP formation but abolished p44/42 MAPK activation. The D298N mutation identified, for the first time, differential structural requirements of the hMC4 receptor for activation of the cAMP and p44/42 MAPK pathways. Furthermore, functional characterizations of a series of chimeric receptors combining the hMC4 receptor and the hMC3 subtype, a receptor that does not couple to p44/42 MAPK activation despite stimulating adenylyl cyclase, indicate that the hMC4 cytoplasmic tail is a necessary structural element for p44/42 MAPK signaling. Subsequent investigation of the signaling requirements for p44/42 MAPK activation demonstrated that the adenylyl cyclase inhibitor 2', 5'-dideoxyadenosine blocked agonist-induced p44/42 MAPK activation, but the PKA inhibitor Rp cAMPS did not. Taken together, these data indicate that cAMP is required, but not sufficient for p44/42 MAPK activation and suggest structural elements required for hMC4 receptor signaling. (C) 2007 Elsevier B.V. All rights reserved.
机构:
NCI, ABL Basic Res Program, Frederick Canc Res & Dev Ctr, Ft Detrick, MD 21702 USANCI, ABL Basic Res Program, Frederick Canc Res & Dev Ctr, Ft Detrick, MD 21702 USA
Jeffers, M
Koochekpour, S
论文数: 0引用数: 0
h-index: 0
机构:
NCI, ABL Basic Res Program, Frederick Canc Res & Dev Ctr, Ft Detrick, MD 21702 USANCI, ABL Basic Res Program, Frederick Canc Res & Dev Ctr, Ft Detrick, MD 21702 USA
Koochekpour, S
Fiscella, M
论文数: 0引用数: 0
h-index: 0
机构:
NCI, ABL Basic Res Program, Frederick Canc Res & Dev Ctr, Ft Detrick, MD 21702 USANCI, ABL Basic Res Program, Frederick Canc Res & Dev Ctr, Ft Detrick, MD 21702 USA
Fiscella, M
Sathyanarayana, BK
论文数: 0引用数: 0
h-index: 0
机构:
NCI, ABL Basic Res Program, Frederick Canc Res & Dev Ctr, Ft Detrick, MD 21702 USANCI, ABL Basic Res Program, Frederick Canc Res & Dev Ctr, Ft Detrick, MD 21702 USA
Sathyanarayana, BK
Vande Woude, GF
论文数: 0引用数: 0
h-index: 0
机构:
NCI, ABL Basic Res Program, Frederick Canc Res & Dev Ctr, Ft Detrick, MD 21702 USANCI, ABL Basic Res Program, Frederick Canc Res & Dev Ctr, Ft Detrick, MD 21702 USA
机构:
Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94141 USAUniv Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94141 USA
Srinivasan, S
Vaisse, C
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94141 USA
Vaisse, C
Conklin, BR
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94141 USA
机构:
Univ Rochester, Dept Pharmacol & Physiol, Med Ctr, Rochester, NY 14642 USAUniv Rochester, Dept Pharmacol & Physiol, Med Ctr, Rochester, NY 14642 USA
Sebag, Julien A.
Hinkle, Patricia M.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Rochester, Dept Pharmacol & Physiol, Med Ctr, Rochester, NY 14642 USAUniv Rochester, Dept Pharmacol & Physiol, Med Ctr, Rochester, NY 14642 USA